Inventor
BADER BENJAMIN
DE32 patents
⚠️ This page may combine multiple inventors who share the name “BADER BENJAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
11 patentsUS9549932B2Jan 24, 2017
2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG26 citations93
US10729680B2Aug 4, 2020
5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG10 citations83
US9993484B2Jun 12, 2018
2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG4 citations83
US11529356B2Dec 20, 2022
2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG1 citations72
US10772893B2Sep 15, 2020
2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG2 citations72
US11040035B2Jun 22, 2021
3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
Bayer Pharma AG2 citations71
US9670202B2Jun 6, 2017
Substituted triazolopyridines
Bayer Pharma AG2 citations62
US10894784B2Jan 19, 2021
Heteroarylbenzimidazole compounds
Bayer Pharma AG0 citations48
US9428460B2Aug 30, 2016
N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products
Bayer Pharma AG0 citations41
US9682995B2Jun 20, 2017
Amino-substituted isothiazoles
Bayer Pharma AG0 citations40
US10167293B2Jan 1, 2019
[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
Bayer Pharma AG0 citations37
BAYER AG
8 patentsUS11304946B2Apr 19, 2022
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists
BAYER AG2 citations71
US11795164B2Oct 24, 2023
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
BAYER AG3 citations70
US11459312B2Oct 4, 2022
Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides
BAYER AG2 citations70
US11524944B2Dec 13, 2022
2-phenylpyrimidine-4-carboxamides as AHR inhibitors
BAYER AG1 citations60
US11998539B2Jun 4, 2024
Substituted aminoquinolones as DGKalpha inhibitors for immune activation
BAYER AG1 citations59
US11591311B2Feb 28, 2023
3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides
BAYER AG1 citations59
US12478621B2Nov 25, 2025
Substituted aminoquinolones as dgkalpha inhibitors for immune activation
BAYER AG0 citations58
US11964953B2Apr 23, 2024
Substituted aminothiazoles as DGKzeta inhibitors for immune activation
BAYER AG0 citations56
KOPPITZ MARCUS
3 patentsSCHULZE VOLKER
3 patentsBAYER SCHERING PHARMA AG
2 patentsUS7977325B2Jul 12, 2011
3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
BAYER SCHERING PHARMA AG31 citations90
US7750000B2Jul 6, 2010
Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
BAYER SCHERING PHARMA AG24 citations88